XTALPI (XtalPi Holdings Limited) disclosed that its board resolved on 9 June 2026 to initiate an on-market share repurchase plan of up to US$100.00 million. The programme will operate under the Repurchase Mandate approved by shareholders on 20 May 2026.

The mandate authorises the company to buy back as many as 430.34 million shares—equivalent to 10% of the total shares outstanding at the time of the May annual general meeting. Repurchases may be executed on the open market from 10 June 2026 until the conclusion of the next annual general meeting, or earlier if the mandate is revoked or varied by shareholders.

XTALPI stated that all transactions will adhere to its memorandum and articles of association, the Hong Kong Listing Rules, the Codes on Takeovers and Mergers and Share Buy-backs, the Companies Act (As Revised) of the Cayman Islands, and other applicable regulations.

Management indicated the buy-back is intended to demonstrate confidence in the company’s business outlook while maintaining a solid financial position.

The board emphasised that repurchases will depend on prevailing market conditions and remain at its discretion; therefore, no assurances were given regarding the timing, quantity, or price of any share repurchase.

The board currently comprises four executive directors—Dr. Wen Shuhao, Dr. Ma Jian, Dr. Lai Lipeng, and Dr. Jiang Yide Alan—and three independent non-executive directors—Mr. Law Cheuk Kin Stephen, Ms. Chan Wing Ki, and Mr. Chow Ming Sang. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.